Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$2.35 - $4.47 $117,500 - $223,500
-50,000 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$4.24 - $9.89 $33,920 - $79,120
8,000 Added 19.05%
50,000 $346,000
Q4 2019

Feb 07, 2020

BUY
$4.56 - $8.78 $191,519 - $368,760
42,000 New
42,000 $358,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $205M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Alpine Woods Capital Investors, LLC Portfolio

Follow Alpine Woods Capital Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.